CELESTIS, INC filed a Form D with the Securities and Exchange Commission on 2026-10-28.
CELESTIS, INC filed a Form D notice of an exempt securities offering with the SEC on October 28, 2026. The filing reports $175K sold. It names Charles Chafer (Executive Officer, Director), Andrea QasGuargis (Executive Officer), Harvin Moore (Executive Officer, Director) (SEC Form D, October 28, 2026).
Is this your company?
Sell to companies like CELESTIS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns CELESTIS, INC.
Free to see. No signup.
Get an email when CELESTIS, INC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when CELESTIS, INC raises, hires or launches. No email unless you switch it on.
Watch CELESTIS, INC →Get the full cited report on CELESTIS, INC
What the filing shows about CELESTIS, INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on CELESTIS, INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives CELESTIS, INC's address as 19535 Champion Forest Drive, Ste B, Spring, TX 77379.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
CELESTIS, INC is a registered filer with the SEC (CIK 2160703) and has filed since 2026-10-28. 1 filing is on record, the latest on 2026-10-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
CELESTIS, INC's Form D of 2026-10-28 names Charles Chafer, Andrea QasGuargis, Harvin Moore and 7 more as its officers, directors or promoters.
Its new offerings report $175K sold across 1 offering, as its own filings state.
Trailing twelve months. 4160 filings in Other, totalled by week. The dot is this raise, $175K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Proceeds are intended for working capital. No specific amount is allocated to executive compensation of persons listed in Item 3, although ordinary-course salaries and benefits may be paid from working capital.
Charles Chafer is named as Executive Officer and Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Andrea QasGuargis is named as Executive Officer on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Harvin Moore is named as Executive Officer and Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Glen Waltrip is named as Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Richard Godwin is named as Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Warren Hackler is named as Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Mark Bohannon is named as Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Catherine Waltrip-Lesch is named as Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Colby Youngblood is named as Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
Donald Rueckert is named as Director on the Form D that CELESTIS, INC filed with the SEC on 28 October 2026, one of 10 people that filing names.
10 people named on the filing — 3 holding an executive role and 7 as directors only.
Named as of the 2026-10-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about CELESTIS, INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on CELESTIS, INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CELESTIS, INC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CELESTIS, INCYou get an alert in MentionFox the next time this company shows up.
If you're behind CELESTIS, INC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for CELESTIS, INC. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/celestis-inc-form-d-000001